ARTICLE SUMMARY:
Scott Gottlieb, MD, former FDA commissioner and special partner at NEA, shares his perspective on the challenges of regulating technologies during COVD-19 and what to expect going forward. From the Innovator’s Workbench Speaker’s Series hosted by the Byers Center for Biodesign at Stanford University, January 21, 2021.
At this year’s first Innovator’s Workbench session from Stanford’s Biodesign program, former FDA Commission Scott Gottlieb, MD, talks about his career as the medtech industry’s top regulator and offers some thoughts on how the COVID pandemic has affected the medical device industry.
